New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Bausch + Lomb Corporation
BLCO
Shape
US Flag

NYSE

7B

Medical - Instruments & Supplies

Next Earning date - 30 Oct 2024

7B

Medical - Instruments & Supplies

Next Earning date - 30 Oct 2024

20.46USD
Shape0.28 ( 1.39%)
favorite-chart

Relative Strenght

11
favorite-chart

Volume Buzz

-59%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

6%

Quote Panel

Shape
Updated October 27, 2024
1W -1.06 % 1M 6.07 % 3M 22.51 % 1Y 25.44 %

Key Metrics

Shape
  • Market Cap

    7.20B


  • Shares Outstanding

    351.90M


  • Share in Float

    38.79M


  • Dividende

    0


  • Earning Date

    30 Oct 2024


  • Price Target

    20.46


  • Average Volume

    744198


  • Beta

    0.478


  • Range

    13.16-21.69


  • Industry

    Medical - Instruments & Supplies


  • Website

    https://www.bausch.com


  • Sector

    Healthcare


Fundamentals

Shape

31.00x

P/E Ratio

1.60x

P/S Ratio

1.11x

P/B Ratio

0.7

Debt/Equity

-10.1%

Net Margin

$-1.3

EPS

How BLCO compares to sector?

P/E Ratio

Relative Strength

Shape

BLCO

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$5B

Shape316%

2025-Revenue

$0.06

Shape85%

2025-EPS

$971M

Shape547%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Evercore ISI

upgrade

Previous: Positive

2024-10-15

Now: Outperform

Raymond James

initialise

Previous: Not converted

2024-07-10

Now: Outperform

Morgan Stanley

upgrade

Previous: Not converted

2024-05-06

Now: Overweight

RBC Capital

initialise

Previous: Not converted

2022-07-26

Now: Outperform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+81%

0.31
vs 0.17

Q4.22

arrow
arrow

+58%

0.23
vs 0.15

Q1.23

arrow
arrow

+75%

0.1
vs 0.06

Q2.23

arrow
arrow

-38%

0.18
vs 0.29

Q3.23

arrow
arrow

-29%

0.22
vs 0.31

Q4.23

arrow
arrow

+4%

0.24
vs 0.23

Q1.24

arrow
arrow

-30%

0.07
vs 0.1

Q2.24

arrow
arrow

-28%

0.13
vs 0.18

Q3.24

arrow
arrow

-28%

0.16
vs 0.22

Q4.24

arrow
arrow

+5%

0.25
vs 0.24

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-1%

942M  vs 949M

Q4.22

arrow
arrow

0%

996M  vs 1B

Q1.23

arrow
arrow

+5%

931M  vs 889M

Q2.23

arrow
arrow

+10%

1B  vs 941M

Q3.23

arrow
arrow

+7%

1B  vs 942M

Q4.23

arrow
arrow

+18%

1.2B  vs 996M

Q1.24

arrow
arrow

+18%

1.1B  vs 931M

Q2.24

arrow
arrow

+17%

1.2B  vs 1B

Q3.24

arrow
arrow

+16%

1.2B  vs 1B

Q4.24

arrow
arrow

+8%

1.3B  vs 1.2B

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

0%

-0.00
vs 0

Q4.22

arrow
arrow

0%

-0.00
vs -0.00

Q1.23

arrow
arrow

-1%

-0.01
vs -0.00

Q2.23

arrow
arrow

0%

-0.00
vs -0.01

Q3.23

arrow
arrow

-1%

-0.01
vs -0.00

Q4.23

arrow
arrow

-1%

-0.01
vs -0.01

Q1.24

arrow
arrow

-3%

-0.03
vs -0.01

Q2.24

arrow
arrow

-2%

-0.02
vs -0.03

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

76

76
vs 78

-3%

Q4.22

arrow
arrow

88

88
vs 76

16%

Q1.23

arrow
arrow

80

80
vs 88

-9%

Q2.23

arrow
arrow

85

85
vs 80

6%

Q3.23

arrow
arrow

92

92
vs 85

8%

Q4.23

arrow
arrow

95

95
vs 92

3%

Q1.24

arrow
arrow

91

91
vs 95

-4%

Q2.24

arrow
arrow

93

93
vs 91

2%

Earnings Growth

Latest News